Top Markets
Coin of the day
SQZ Biotechnologies Company SQZ Biotechnologies Company

SQZ Biotechnologies Company

SQZ
Rankning i aktier #38920
SQZ Biotechnologies, a biotechnology firm currently in the clinical development... SQZ Biotechnologies, a biotechnology firm currently in the clinical development phase, is focused on creating cell-based therapies for various severe ailments, including cancerous growths, autoimmune disorders, and infectious diseases. Its primary experimental therapeutic, known as SQZ-PBMC-HPV, is derived from its SQZ Antigen Presenting Cells technology. This treatment is currently undergoing Phase I clinical trials, both as a standalone therapy and alongside other immune-oncology treatments, to address advanced or metastatic solid tumors positive for HPV16, encompassing cancers of the cervix, head-and-neck, anus, penis, vulva, and vagina. Furthermore, the company is progressing with SQZ-AAC-HPV, another Phase I clinical candidate targeting the same HPV16+ advanced or metastatic solid tumors, which is also being evaluated as a single agent and in conjunction with other immune-modulating agents. Beyond these, SQZ Biotechnologies is also advancing its SQZ Activating Antigen Carriers and SQZ Tolerizing Antigen Carriers platforms. Established in 2013, the company operates from its main office in Watertown, Massachusetts.
Aktiekurs
$0.05083
Senast synkroniserad: 2023-09-01
Marknadsvärde
$732.57K
Förändring (1 dag)
8.15%
Förändring (1 år)
0.00%
Land
US
Handel SQZ Biotechnologies Company (SQZ)

Kategori

P/S-tal för SQZ Biotechnologies Company (SQZ)
P/S-tal per 2026 TTM: 0
Enligt SQZ Biotechnologies Company senaste finansiella rapporter och aktiekurs är det aktuella P/S-talet (TTM) 0. I slutet av 2026 hade företaget ett P/S-tal på 0.
Historik för P/S-tal för SQZ Biotechnologies Company från 2026 till 2026
P/S-tal vid årets slut
År P/S-tal Ändra
Inte tillräckligt med data för de angivna datumen.
P/S-tal för liknande företag eller konkurrenter
Företag P/S-tal Skillnad i P/S-tal Land
9.88 -
US
10.30 -
NL
- -
CH
- -
KR
4.98 -
BE